75 results on '"Schilling D"'
Search Results
2. Radiobiological Characterization of Pancreatic Cancer Patient-Derived Organoids
3. Exosomes from mistletoe treated tumor cells for the stimulation of immune cells
4. Radiation Response after High-Precision Radiotherapy in an Orthotopic Pancreatic Tumor Mouse Model
5. PO-1035: Detection of radiation induced lung fibrosis using x-ray dark-field imaging in a murine model
6. EP-2323: Effects of the proteasome inhibitor bortezomib on radiosensitivity of glioblastoma cells
7. EP-2320: The impact of high and low-LET irradiation on the invasion of glioblastoma cells
8. EP-2326: Downregulation of ALDH1A1 reduces radioresistance and migration of glioblastoma cells
9. EP-2330: MRI based high precision irradiation of a pancreatic tumor using SARRP: a treatment planning study
10. EP-2304: Selenium does not affect radiosensitivity of human breast cancer cell lines
11. Prediction of individual nodal involvement based on Sentinel-node dissection of prostate cancer
12. OC-0127: Individualized prediction of nodal involvement based on Sentinel-node dissection of prostate cancer
13. In vitro assessment of the hydrodynamic clearance of stone fragments and dust in percutaneous nephrolithotomy instruments
14. EP-2051: Hsp70 as a tumor specific biomarker in primary glioblastoma multiforme patients
15. PO-0740: Nodal clearance rate and efficacy of individualised SN-based pelvic IMRT for prostate cancer
16. 1069 Intratumoral heterogeneity of mTOR-pathway parameters in prostate cancer
17. 591 Flow matters – how to improve irrigation flow in small calibre percutaneous procedures: The purging effect
18. 586 The novel miniaturized amplatz sheaths of 8.5Ch and 11Ch inner diameter manage to maintain low intrapelvic irrigation pressure during minimal invasive percutaneous nephrolitholapaxy: Results from an ex-vivo organ-model study on pressure-measurement and histological evaluation of papillary reflux
19. 285 CCL2 promotes integrin-mediated adhesion of prostate cancer cells
20. 419 Individual risk for biochemical recurrence in localized prostate cancer with positive surgical margins: A multicentre study
21. EP-1330: Individual risk for biochemical recurrence in T2/T3a R1 prostate cancer - a multicenter study
22. PO-0736: Pattern of failure after sentinel node based individualization of pelvic IMRT for high risk prostate cancer
23. EP-1089: Serum levels of soluble Heat shock protein 70 (sHsp70) correlate to tumor response after radical treatment of SCCHN
24. EP-1836: Radiation-induced modulation in the distribution of lymphocytes in breast cancer patients
25. O6 Sentinel node based individualization of pelvic IMRT for high risk prostate cancer
26. 1022 Bilateral peritoneal incision in open retropubic prostatectomy does not seem to lower rates of symptomatic lymphoceles
27. V59 En-bloc resection of non-muscle invasive bladder tumours with the combination instrument HybridKnife®
28. 964 Efficacy and safety in the treatment of large renal calculi with minimally invasive or conventional large bore PCNL: A retrospective comparison of two longitudinal databases
29. P097 Posttranslational modification of prostate-specific phosphodiesterase 11A4 in prostate carcinoma
30. 233 THE INFLUENCE OF THE HEAT SHOCK PROTEIN 90 (HSP90) INHIBITOR, NVP-AUY922, AND HYPOXIA ON THE EXPRESSION OF HIF-1α AND HIF-2α IN TWO HEAD AND NECK CANCER CELL LINES
31. 1031 The minimally invasive PCNL (MIP): Comparison study between the management of small and large sized renal stones
32. 452 Incidence of symptomatic lymphoceles after radical prostatectomy depends on surgical method, extent of resection and body mass index
33. 774 External validation of current nomograms in invasive bladder cancer and proposal of a new prognostic models for survival after radical cystectomy based on preoperative haematological disorders
34. 521 Endoscopic inguinofemoral lymphadenectomy for penile malignancies – extended follow-up
35. 760 A NEW OUTCOME PREDICTION MODEL IN INVASIVE BLADDER CANCER BASED ON PREOPERATIVE SERUM C-REACTIVE PROTEIN AND STANDARD PATHOLOGIC RISK FACTORS: THE TNR-C SCORE
36. 840 DIFFERENTIAL ISOLATION AND SURFACE MARKER CHARACTERIZATION OF EPITHELIAL AND STROMAL STEM CELLS IN BENIGN PROSTATE TISSUE
37. 415 HISTOLOGICAL SERIAL SECTION ANALYSIS OF PELVIC LYMPH NODES DOES NOT IMPROVE STAGING ACCURACY IN PROSTATE CANCER
38. 199 POST-PUBERTAL OUTCOME AFTER DISTAL HYPOSPADIAS REPAIR IN CHILDHOOD USING THE MEATAL MOBILIZATION (MEMO) TECHNIQUE
39. 151 SECOND-LINE APPLICATION OF URINE-BASED MOLECULAR MARKERS IN TRANSITIONAL CARCINOMA DIAGNOSTICS -A CONTRIBUTION TO COST EFFECTIVENESS
40. 710 PREOPERATIVE ENDORECTAL COIL MRI: SENSITIVITY AND SPECIFICITY VARY IN DIFFERENT REGIONS OF THE PROSTATE
41. 978 EVIDENCE FOR AN AGE DEPENDENCE OF THE PROSTATE CANCER ANTIGEN 3 (PCA3) SCORE
42. 316 SUBSTRATIFICATION IN NODE-NEGATIVE PT2 BLADDER CANCER IS AN INDEPENDENT PREDICTOR FOR RECURRENCE-FREE SURVIVAL: A CONTEMPORARY SERIES
43. 26 DOES THE PCA3 SCORE DEPEND ON TUMOR LOCALIZATION WITHIN THE PROSTATE? A MORPHOMETRIC COMPUTER ANIMATED ANALYSIS
44. 216 ENDOVASCULAR MANAGEMENT OF URETERO-ARTERIAL FISTULA DUE TO LONG-TERM URETHRAL STENTING
45. 53 IMPACT OF URINARY SAMPLING AND URINARY TRACT INFECTION ON THE DIAGNOSTIC VALUE OF URINE TESTS (UROVYSIONR, UCYT+R) AND CYTOLOGY FOR TRANSITIONAL CELL CARCINOMA – RESULTS FROM A COHORT OF 2077 PATIENTS
46. 30 LOCALISATION OF PROSTATE CANCER METASTASES WITHIN THE LYMPH NODE: SUFFICIENT HISTOLOGICAL EVALUATION DEMANDS ANALYSIS OF MORE THAN ONE SECTION
47. 801 THE SINGLE STAGE DORSAL INLAY SKIN GRAFT FOR COMPLEX HYPOSPADIAS REOPERATIONS: LONG-TERM FOLLOW-UP
48. 31 MORPHOLOGIC GROWTH PATTERNS OF LYMPH NODE METASTASES PREDICT EXTENT OF TUMOUR EXPANSION IN PROSTATE CANCER
49. 378 DORSAL INLAY SKIN-GRAFT URETHROPLASTY IN PATIENTS OLDER THAN 65 YEARS
50. 804 LONG-TERM OUTCOME OF MALES WITH DISORDERS OF SEXUAL DIFFERENTIATION (DSD)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.